| Charles Michael Labuwi, MD | |
|
2310 Mountain View Blvd, Klamath Falls, OR 97601-1134 | |
| (541) 883-3591 | |
| (541) 883-2886 |
| Full Name | Charles Michael Labuwi |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 2310 Mountain View Blvd, Klamath Falls, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215022934 | NPI | - | NPPES |
| 005082 | Medicaid | OR | |
| XPY183282 | Other | CA | MEDICAL OF CALIFORNIA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 11278 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Charles Michael Labuwi, MD 2310 Mountain View Blvd, Klamath Falls, OR 97601-1134 Ph: (541) 883-3591 | Charles Michael Labuwi, MD 2310 Mountain View Blvd, Klamath Falls, OR 97601-1134 Ph: (541) 883-3591 |
News Archive
YM BioSciences Inc., today announced that the first US patient has been enrolled in its randomized, double-blind trial evaluating nimotuzumab in patients with brain metastases from NSCLC at the Florida Cancer Institute - New Hope. This trial initiation follows recent clearance from the US FDA announced on January 26, 2010 allowing the Company to enroll patients at US clinical sites for two of its international and ongoing randomized, double-blind Phase II trials of nimotuzumab.
Important advances in the fight against cancer have come as researchers proved that viruses and cancers interact in ways that were previously unknown to scientists.
Researchers at the National Institutes of Health and the University of Wisconsin have demonstrated that using artificial intelligence to analyze CT scans can produce more accurate risk assessment for major cardiovascular events than current, standard methods such as the Framingham risk score and body-mass index.
Intrasphere Technologies, a Drug Safety specialized consulting and solutions firm that provides services to Life Sciences organizations, today announced that it has launched SafetyXpress. SafetyXpress for Argus is Intrasphere's proprietary implementation accelerator framework for the rapid deployment of the Argus Safety suite. Intrasphere is a Specialized Oracle Argus Safety Gold Partner.
The Food and Drug Administration (FDA) received reports of malignancies in children using tumor necrosis factor (TNF) blockers, raising concerns of an associated risk and prompting an investigation. Researchers from the FDA set out to identify all reports of malignancy in children using infliximab, etanercept, and adalimumab and their report is published in the August issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology.
› Verified 6 days ago
Dr. Carrie Atwell Ganong, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3001 Daggett Ave, Klamath Falls, OR 97601 Phone: 541-851-4800 Fax: 541-851-4801 | |
Dr. Nicola J Cherry, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 2580 Daggett Ave, Klamath Falls, OR 97601 Phone: 541-884-1224 Fax: 541-884-8030 | |
Dr. Frederick L Zwartverwer, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3001 Daggett Ave, Klamath Falls, OR 97601 Phone: 541-851-4800 Fax: 541-851-4801 | |
John Aaron Wilson, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3001 Daggett Ave, Klamath Falls, OR 97601 Phone: 541-851-4800 Fax: 541-851-4801 | |
Tracy Warwick Graham, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 706 Main St Ste 2a, Klamath Falls, OR 97601 Phone: 541-851-7350 Fax: 541-851-7351 |